Systematic effects of patient factors and scanner/protocol factors on a Restriction Spectrum Imaging (RSI) quantitative MRI biomarker for prostate cancer.
Do DD, Domingo MR, Conlin CC, Matthews I, Kallis K, Baxter MT, Ollison C, Song Y, Xu G, Zhong AY, Bagrodia A, Barrett T, Cooperberg M, Feng F, Hahn ME, Harisinghani M, Hollenberg GM, Javier-Desloges J, Kamran SC, Kane CJ, Kessler D, Kuperman J, Lee KL, Levine J, Liss MA, Margolis DJA, Murphy PM, Nakrour N, Ohliger MA, Osinski T, Pamatmat AJ, Pompa IR, Rakow-Penner R, Roberts JL, Santhosh K, Shabaik AS, Song D, Tempany CM, Trecarten S, Wehrli N, Weinberg EP, Woolen S, Dale AM, Seibert TM.
Do DD, et al. Among authors: feng f.
Cancer Imaging. 2026 Apr 16. doi: 10.1186/s40644-026-01032-w. Online ahead of print.
Cancer Imaging. 2026.
PMID: 41992373
Free article.
No abstract available.